BioCentury
ARTICLE | Company News

Chiroscience, MIT deal

July 19, 1999 7:00 AM UTC

CRO received an exclusive worldwide license from MIT to catalysts for asymmetric olefin metathesis, which CRO will develop for use in its chiral products business. Metathesis is a synthetic reaction t...